SCHEMBL21908095

SCHEMBL21908095

C=C(C)c1c(C(C)C)noc1C1CC1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.35
RET P07949 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21187534 0.83 RET (0.42) RET
SCHEMBL21191323 0.79 RET (0.45) RET
SCHEMBL21187545 0.76 RET (0.45) RET
SCHEMBL24632318 0.76
SCHEMBL24490662 0.75
SCHEMBL24192087 0.75 RET (0.31) RET
SCHEMBL21191286 0.73 RET (0.36) RET
SCHEMBL21907115 0.73 RET (0.33) RORCRET
SCHEMBL21187547 0.72 RET (0.38) RET
SCHEMBL24632337 0.71 RET (0.41) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055672-A1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-03-19 WO disclosed